In addition, IKKβ targeting reduces prostate cancer tumoursphere formation and expression of stem cell factors [45], as well as reduces the ability of CD133+ glioblastoma TICs to form tumourspheres [46]. The gene discussed is IKBKB; the disease is prostate carcinoma.